Curating from trusted global sources…
5 briefings · “marketing”
The global pushback at an event in Paris is reshaping how Israel’s weapons makers sell, frame, and defend themselves.
The dispute centers on whether Lilly is using the most up-to-date clinical information in its marketing, and why it matters in the GLP-1 land grab.
The marketing pivot from “evergreen” stunts to live moments helped drive a monoculture-shaped spike, and AI may be amplifying it.
The lawsuit alleges Lilly's Zepbound and Mounjaro marketing leans on stale evidence to exaggerate efficacy versus rivals.
A court filing asks to block Lilly’s GLP-1 advertising and force corrections, raising the heat on drug marketing scrutiny.
